Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 200,000 shares at $35.09 ($7.0M) on 2019-01-08, disclosed to the SEC on 2019-01-10.
Open-market sale of $7.0M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.09 | 17,310 | $607K | 8.7% |
| 2 | $35.09 | 17,310 | $607K | 8.7% |
| 3 | $35.01 | 82,690 | $2.9M | 41.3% |
| 4 | $35.01 | 82,690 | $2.9M | 41.3% |
| Total | $35.02 avg | 200,000 | $7.0M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |